ECs have been shown to support malignant B cell survival in CLL and NHL through several mechanisms such as production of BAFF and APRIL (CLL) and inhibition of helper CD4+ T cells and Th1 polarization (DLBCL) [85,86]. Here, TNFSF13B is linked to B-cell chronic lymphocytic leukemia.